glp-1 agonists alternatives to ozempic Compare Options | v Mounjaro | WeightWatchers Study Finds Similar Rates of

Unlike quick fixes, this formula harnesses clinically studied ingredients that help your body burn fat for energy, balance blood sugar levels, and minimize fat accumulation while preserving lean mass

A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases

While effective, these treatments require monitoring due to potential side effects, especially in non-diabetic patients.This therapeutic advancement represents a revolution in the management of metabolic diseases and obesity.Despite their efficacy in managing obesity and metabolic disorders, GLP-1 and GIP receptor agonists can cause side effects, which are a common reason for therapy discontinuation

Next up: glucagon-like peptide 1 receptor agonists, known colloquially (and identified here) as GLPs

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data